Abstract | OBJECTIVE: METHODS: A 1:2 matched case-control study was conducted with 63 cases of EC and 126 controls involved. The controls were matched by sex, nationality, area of residence and age within 5-year difference. HPV16E6 and HLA-DR9 allele were identified by PCR-SSP. Interaction was performed to identify risk factors. RESULTS: HPV16E6 infection and HLA-DR9 allele positive status were the risk factors for EC, with OR values as 2.67 (95%CI: 1.38 - 5.17) and 3.83 (95%CI: 1.48 - 9.96) respectively. The rate of HPV16E6 infection in individuals with HLA-DR9 allele was different from the ones who were HLA-DR9 allele free (chi(2) = 7.57, P = 0.006), with OR value as 5.79 (95%CI: 1.53 - 21.87). In the controls, the rates of HPV16E6 infection were 22.2% and 16.2% among individuals with HLA-DR9 allele atatus as positive or negative, and without statistically significant difference. Interaction analysis showed there was an interaction of HPV16E6 with HLA-DR9 and were higher than the sum of the two factors presented individually. CONCLUSION: In our study, we found that the HLA-DR9 allele and HPV16E6 infection had a function of synergy in the process of malignant transformation of esophageal epithelial cells, and jointly promoting the occurrence and development of EC.
|
Authors | Pei-hua Liao, Jiang-mei Qin, Tong-xia Zeng, Feng Li, Jin-feng Cai, Ling He |
Journal | Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
(Zhonghua Liu Xing Bing Xue Za Zhi)
Vol. 30
Issue 9
Pg. 951-4
(Sep 2009)
ISSN: 0254-6450 [Print] China |
PMID | 20193235
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- E6 protein, Human papillomavirus type 16
- HLA-DR Antigens
- HLA-DR Serological Subtypes
- HLA-DR9 antigen
- Oncogene Proteins, Viral
- Repressor Proteins
|
Topics |
- Alleles
- Case-Control Studies
- Cell Transformation, Neoplastic
(genetics)
- China
(epidemiology)
- Epithelial Cells
(pathology)
- Esophageal Neoplasms
(ethnology, etiology, genetics)
- Esophagus
(pathology)
- HLA-DR Antigens
(genetics)
- HLA-DR Serological Subtypes
- Humans
- Oncogene Proteins, Viral
- Papillomavirus Infections
(complications)
- Polymerase Chain Reaction
- Repressor Proteins
- Risk Factors
|